A Study of Romiplostim to Prevent Low Platelet Counts in Children and Young Adults Receiving Chemotherapy for Solid Tumors

Clinical trial NCT04671901 · TERMINATED

Trial details

NCT number: NCT04671901
Sponsor: Memorial Sloan Kettering Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Solid Tumor Solid Tumor, Childhood Solid Carcinoma

Start date: 2020-12-10
Primary completion: 2023-03-29
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.